• Wakako Fukuda, Mari Chiyoya, Satoshi Taniguchi, Kazuyuki Daitoku, and Ikuo Fukuda.
• Department of Thoracic and Cardiovascular Surgery, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, 036-8562, Japan.
• Gen Thorac Cardiovasc Surg. 2016 Jun 1; 64 (6): 309-14.

PurposeThe risk of venous thromboembolism (VTE) is high during pregnancy. Although most patients with VTE are safely treated via medications, the optimal treatment for massive pulmonary embolism remains controversial. To evaluate the safety and efficacy of VTE management during pregnancy, we report our single center experience of treating VTE in pregnant women.MethodsCase records were retrospectively reviewed from seven patients who underwent treatment for venous thromboembolism between 2002 and 2014.ResultsMean gestational time was 28 ± 6.2 weeks. Four patients with deep vein thrombosis were treated medically, and they all had vaginal delivery at full term without hemorrhagic complication. Three patients with massive pulmonary embolism underwent surgical embolectomy. Two of these three patients underwent cesarean delivery at 28 and 29 weeks respectively. There was no maternal death, but one fetal death occurred during surgical embolectomy.ConclusionVTE during pregnant women is safely managed by anticoagulant therapy. Massive pulmonary embolism during pregnancy can be managed safely by surgical embolectomy using cardiopulmonary bypass, but the rate of fetal loss remains high.

25 keywords...

hide…